Literature DB >> 19937831

Transporters in absorption, distribution, and elimination.

Jean-Michel Scherrmann1.   

Abstract

During the past decades, pharmacokinetics has been defined as the study of drug absorption, distribution, metabolism, and excretion (ADME), when the drug is introduced into a biological system, such as the human body. Pharmacokinetics is now challenged by the growing importance of transporters, a relatively new and potentially major factor in drug ADME. The recent intrusion of drug transporters means that there is no single mechanism by which drugs permeate through membranes. The presence of transporters in membranes modulates the traditional theory of 'diffusional pharmacokinetics' towards 'vectorial pharmacokinetics' in which ADME processes are governed more deterministically. Drug transporters are also clinically important. They can modulate the pharmacological activity of drugs by affecting their intracellular concentrations and causing toxicity in specific organs due to intracellular drug accumulation. Finally, they are key players in drug-drug interactions, where they are as important as the drug metabolizing enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937831     DOI: 10.1002/cbdv.200900171

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  7 in total

Review 1.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

2.  Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates.

Authors:  Nicolas Tournier; Salvatore Cisternino; Marie-Anne Peyronneau; Sébastien Goutal; Frédéric Dolle; Jean-Michel Scherrmann; Michel Bottlaender; Wadad Saba; Héric Valette
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

3.  Enhanced solubility and intestinal absorption of candesartan cilexetil solid dispersions using everted rat intestinal sacs.

Authors:  S Gurunath; Baswaraj K Nanjwade; P A Patila
Journal:  Saudi Pharm J       Date:  2013-04-08       Impact factor: 4.330

Review 4.  Medicine in the Fourth Dimension.

Authors:  Christopher R Cederroth; Urs Albrecht; Joseph Bass; Steven A Brown; Jonas Dyhrfjeld-Johnsen; Frederic Gachon; Carla B Green; Michael H Hastings; Charlotte Helfrich-Förster; John B Hogenesch; Francis Lévi; Andrew Loudon; Gabriella B Lundkvist; Johanna H Meijer; Michael Rosbash; Joseph S Takahashi; Michael Young; Barbara Canlon
Journal:  Cell Metab       Date:  2019-08-06       Impact factor: 27.287

5.  A new nonpolar N-hydroxy imidazoline lead compound with improved activity in a murine model of late-stage Trypanosoma brucei brucei infection is not cross-resistant with diamidines.

Authors:  Carlos H Ríos Martínez; Florence Miller; Kayathiri Ganeshamoorthy; Fabienne Glacial; Marcel Kaiser; Harry P de Koning; Anthonius A Eze; Laura Lagartera; Tomás Herraiz; Christophe Dardonville
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

6.  Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.

Authors:  Vincent J C Lempers; Jeroen J M W van den Heuvel; Frans G M Russel; Rob E Aarnoutse; David M Burger; Roger J Brüggemann; Jan B Koenderink
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

Review 7.  Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs.

Authors:  Raymond E Lai; Christopher E Jay; Douglas H Sweet
Journal:  J Food Drug Anal       Date:  2018-03-24       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.